Omar Green

Dr. Green is formally trained as a chemist, which has provided the necessary scientific background to contribute to a diverse group of projects. He has applied his chemical expertise to spectroscopic and materials research. From 2010-2013, Dr. Green served as Lead Chemist with Agave BioSystems, in Ithaca, NY. In this capacity, his research proposals garnered $2.4 mil in funding. He has continued building on this track record at Ionica, which has garnered $250,000 in Phase I funding in its first 9 months of existence.​

His experience in spectroscopy has allowed him to design a novel method for the detection of trihalomethanes (THMs) that does not require the use of caustic materials or the heating of organic solvents. This Phase II effort was selected as a “Success Story” by the Air Force. Dr. Green has served as the lead on multiple other Phase I projects for the Department of Defense SBIR, including the development of DNA-based nanoparticles for use as anti-sense “modular medicines” capable of being tailored to the needs of specific patients (Phase I & II), development of nanoparticles for transdermal detection of chemical warfare agents (Phase I & II), and development of metal-containing polymers for luminescent detection of VOCs (Phase I).​

Dr. Green received his Hon. B.Sc. from the University of Toronto with distinction in 1999 before receiving his Ph. D. in chemistry from the University of Wisconsin-Madison in 2005, where he worked with Professor J. N. Burstyn on the design and investigation of small molecule sensors using luminescent transition metal-based methods. He then completed two-year postdoctoral stints at the California Institute of Technology (Caltech; 2006-2007) and Argonne National Laboratory (ANL; 2007-2009). At Caltech, Dr. Green investigated DNA/protein interactions using electrochemical methods. While at ANL, he joined the biomaterials group, which focused on the investigation of the self-assembly of ionic liquids for application as supports for biomolecules.

Dr. Green has published five peer-reviewed papers, including a review of polymerized ionic liquids, has been issued two patents, and has presented at multiple professional meetings, and has garnered over $2.5 million in SBIR/STTR funding over the last 3 years.